Serum Cell Division Cycle 42 before and after Programmed Death-1 Inhibitor Therapy in Advanced Melanoma Patients: Correlation with Tumor Features, Clinical Response, and Survival

Tohoku J Exp Med. 2023 Nov 2. doi: 10.1620/tjem.2023.J091. Online ahead of print.NO ABSTRACTPMID:37914283 | DOI:10.1620/tjem.2023.J091

Source: The Tohoku Journal of Experimental Medicine - November 1, 2023 Category: Research Authors: Ling Zhang Shenglan Zhang Zhao Han Zhao Liu Yanyan Xu Xiaojing Li Guoying Miao Liang Niu Source Type: research